GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige BioPharma Ltd (XKRX:950210) » Definitions » Tax Provision

Prestige BioPharma (XKRX:950210) Tax Provision : ₩-283 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Prestige BioPharma Tax Provision?

Prestige BioPharma's tax provision for the three months ended in Dec. 2024 was ₩167 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-283 Mil.


Prestige BioPharma Tax Provision Historical Data

The historical data trend for Prestige BioPharma's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige BioPharma Tax Provision Chart

Prestige BioPharma Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Tax Provision
-98.47 -34.08 -800.66 -763.28 -408.68

Prestige BioPharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.35 -144.27 -157.15 -148.47 167.27

Prestige BioPharma Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-283 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prestige BioPharma Business Description

Traded in Other Exchanges
N/A
Address
2 Science Park Drive No. 04-13/14, Ascent Tower B, Singapore Science Park, Singapore, SGP, 118222
Prestige BioPharma Ltd is a biopharmaceutical company. The company is focused on the development of biosimilars and new antibody therapeutics. It focuses on oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis.

Prestige BioPharma Headlines

No Headlines